Janet K. Parrish

A novel oncogenic mechanism in Ewing sarcoma involving IGF pathway targeting by EWS/Fli1-regulated microRNAs

Erin McKinsey, Janet K. Parrish, Brian F. Niemeyer et al. · Oncogene · 2011 · 110 citations

Medicine, Genetics, Oncology +17

The histone demethylase KDM3A is a microRNA-22-regulated tumor promoter in Ewing Sarcoma

Janet K. Parrish, Marybeth Sechler, R A Winn et al. · Oncogene · 2013 · 83 citations

Life Sciences, Genetics, Molecular Biology +14

The histone demethylase KDM3A, and its downstream target MCAM, promote Ewing Sarcoma cell migration and metastasis

Marybeth Sechler, Janet K. Parrish, Diane K. Birks et al. · Oncogene · 2017 · 69 citations · Full text

Medicine, Molecular Biology, Oncology +15

Molecular characterization and embryonic expression of the even-skipped ortholog of Tribolium castaneum

Susan J. Brown, Janet K. Parrish, Richard W. Beeman et al. · Mechanisms of Development · 1997 · 67 citations

Life Sciences, Molecular Biology, Molecular Genetics +6

The Jumonji-domain histone demethylase inhibitor JIB-04 deregulates oncogenic programs and increases DNA damage in Ewing Sarcoma, resulting in impaired cell proliferation and survival, and reduced tumor growth

Janet K. Parrish, Tyler McCann, Marybeth Sechler et al. · Oncotarget · 2018 · 54 citations · Full text

Medicine, Cancer Biology, Oncology +17